Mouse and human induced pluripotent stem cells (iPSCs) may represent a novel approach for modeling diabetes. Taking this into consideration, the aim of this study was to generate and evaluate differentiation potential of iPSCs from lep db/db (db/db) mice, the model of diabetes type 2 as well as from patients with Maturity Onset Diabetes of the Young 3 (HNF1A MODY). Murine iPSC colonies from both wild type and db/db mice were positive for markers of pluripotency: Oct3/4A, Nanog, SSEA1, CDy1 and alkaline phosphatase and differentiated in vitro and in vivo into cells originating from three germ layers. However, our results suggest impaired differentiation of db/db cells into endothelial progenitor-like cells expressing CD34 and Tie2 markers and their reduced angiogenic potential. Human control and HNF1A MODY reprogrammed cells also expressed pluripotency markers: OCT3/4A, SSEA4, TRA-1-60, TRA-1-81, formed embryoid bodies (EBs) and differentiated into cells of three germ layers. Additionally, insulin expressing cells were obtained from those partially reprogrammed cells with direct as well as EB-mediated differentiation method. Our findings indicate that disease-specific iPSCs may help to better understand the mechanisms responsible for defective insulin production or vascular dysfunction upon differentiation toward cell types affected by diabetes.
D
iabetes mellitus is a group of complex metabolic diseases affecting more than 300 million people worldwide 1 . The most common form is type 2 diabetes (T2D) which is characterized by the lack of proper response to insulin in the peripheral tissues, a phenomenon known as the insulin resistance 2 . Additionally, T2D is accompanied by relative insulin deficiency resulting from defects in the secretion of this hormone 3 . Among others, this disease is also closely associated with cardiovascular complications, with endothelial cells being significantly affected 4 . Lep db/db is a mouse strain frequently utilized as T2D model with the mutation in leptin receptor resulting in hyperphagy, obesity, hyperinsulinemia and hyperglycemia, the latter three reflecting clinical features of T2D patients 5, 6 . Importantly, animal models based on disturbed leptin activity are often used to test new therapeutic approaches against T2D 7, 8 . In contrast to T2D, monogenic forms of diabetes are rather rare, with the maturity onset of diabetes of the young (MODY) being the most frequent among them, constituting 1-2% of diabetic cases 9 . HNF1A MODY (MODY3) is the most common form which results from the mutations in hepatocyte nuclear factor 1 alpha (HNF1A) gene 10 . This nuclear receptor is expressed in several organs, including pancreas, and controls the production of multiple factors responsible for glucose uptake, glycolysis and mitochondrial metabolism. Patients with MODY3 usually suffer from postprandial hyperglycemia and require pharmacological treatment with sulphonylureas or, in later stage, with insulin 11 . The molecular basis of this disease, similarly to T2D, has been characterized with the application of cell lines and animal models 12 , however utilization of patient-specific biological material could significantly enlarge our knowledge on the mechanisms of defective insulin production by the pancreatic b cells.
Induced pluripotent stem cells (iPSCs) which resemble embryonic stem cells with their infinite self-renewal capacity as well as the ability to differentiate into all cell types constituting adult organism 13, 14 , may provide the new possible source of such patient-specific material. Indeed, many groups demonstrated a feasibility of generating human iPSCs from patients suffering from different illnesses including metabolic disorders like type 1 and 2 of diabetes 15, 16 as wells as five forms of MODYs 17, 18 . Some of these studies described differentiation of hiPSCs towards insulin-producing cells 18 , however further optimization of this process seems to be necessary, especially for different types of MODYs. Additionally, iPSCs have been obtained from murine model of type 1 diabetes 19 but not the others. Here we report successful generation of induced pluripotent stem cells from the Lep db/db mice as the animal model of T2D as well as reprogrammed cells from patients diagnosed with HNF1A MODY. Additionally, this study demonstrates the feasibility of production of such cells to investigate the effects of diabetes on different cell types. Generated iPSCs can be further utilized to analyze the molecular mechanisms responsible for pathophysiology of diabetic disorders or be used for drug screening.
Results
Generation and characterization of mouse db/db iPSCs. Transduction of tail tip fibroblasts isolated from control wild type (WT) and Lep db/db mice with STEMCCA lentiviral vectors resulted in generation of multiple colonies (within 2-3 weeks of reprogramming process) resembling mouse embryonic stem cells which could be further picked up and expanded ( Figure 1A ). No differences between cells from WT and Lep db/db mice were observed. This indicates that leptin signaling, which is disturbed in db/db cells is not required for proper reprogramming outcome. Additionally, no changes in morphology of db/db iPSCs were noticed in comparison to control counterparts as well as in the expression of pluripotency markers like Oct3/4A, Nanog and Sox2, both at mRNA and protein levels ( Figure 1A -C). Expression of these transcription factors, which are the crucial components of self-renewal-and pluripotency-regulating signaling network, additionally indicated successful generation of induced pluripotent stem cells. Both WT and db/db iPSCs presented abundantly the SSEA1 carbohydrate epitopes, bound CDy1 dye ( Figure 1C ), and expressed alkaline phosphatase ( Figure 1D ). On the other hand, Hmox1 (heme oxygenase-1), Prt4 (proteoglycan-4), and Agt (angiotensinogen) showed a tendency toward lower expressions in db/db iPSCs than in WT cells ( Figure 1E ). This observation seems interesting, as proteoglycan-4 can promote development of hemangioblasts 20 and similar role has been ascribed to the angiotensin converting enzyme 21 , whereas heme oxygenase-1 is a proangiogenic enzyme necessary for proper function of endothelial progenitors 22 .
To further verify the pluripotency of iPSCs, they were subjected to spontaneous differentiation process through the formation of embryoid bodies (Figure 2 ). Indeed, after removal of feeder layer and LIF (leukemia inhibitory factor) stimulation, control and db/ db iPSCs generated EBs which adhered to gelatin-coated wells (Figure 2A,B) . Importantly, immunofluorescence analysis confirmed the expression of markers of different germ layers in the control and db/db cells that further outgrew from the adhered EBs ( Figure 2C,D) . Finally, subcutaneous injection of either control or db/db iPSCs into immunocompromised mice resulted in formation of teratomas which were composed of tissues characteristic for endoderm, mesoderm and ectoderm ( Figure 2E,F) . This experiment proved that both WT iPSCs and those generated from Lep db/db animals were pluripotent. Additionally, this demonstrated that functional leptin receptor is not crucial for the maintenance of pluripotency in iPSCs.
Endothelial differentiation of control and db/db iPSCs. To stimulate endothelial differentiation, control and db/db iPSCs were seeded on collagen IV to induce differentiation into mesoderm lineages and subsequently cultured on fibronectin in the presence of vascular endothelial growth factor (VEGF) to direct the process toward endothelial cells 23 . Of note, the fraction of CD34 1 Tie-2 1 subpopulation was much lower within differentiating db/db cells than in control counterparts (14.3% versus 88.4% at day 60 of differentiation, Figure 3A ), suggesting that functional leptin signaling might influence this process. Nevertheless, either control or db/db cells acquired characteristic endothelial-like cobblestone morphology ( Figure 3B ), and expressed endothelial markers, such as von Willebrand Factor (vWF), phosphorylated endothelial nitric oxide synthase (eNOS), and vascular endothelial growth factor receptor 1 (Flt-1) ( Figure 3C ). Phosphorylation of eNOS protein indicated its enzymatic activity. Indeed, the iPSC-derived endothelial progenitor-like cells produced nitric oxide (NO), with the same efficacy for both genotypes ( Figure 3D ). Then, we compared the angiogenic potential of the iPSC-derived cells using a capillary sprouting assay ( Figure 3E ). Cells were suspended in medium containing methyl cellulose and seeded in Ushaped 96-well plate to form spheroids, which were subsequently embedded in collagen and stimulated with VEGF to produce capillary-like sprouts. The number and length of sprouts were analyzed after 48 h, but in WT spheroids the outgrowth of sprouts was visible already after 24 h. In contrast, db/db spheroids formed almost no capillary-like structures ( Figure 3E,F) . Namely, we demonstrated a significant impairment both in number and length of capillary like structures ( Figure 3F ). This observation suggests that cells obtained after endothelial differentiation of db/db iPSCs display impaired angiogenic potential, the feature typical for endothelial cells isolated from db/db mice. Indeed, we found a very similar impairment when spheroids were formed by CD34
1 primary endothelial cells isolated from the lungs of wild type or db/db mice ( Figure 3G ).
Generation and characterization of HNF1A MODY reprogrammed cells. Similarly to mouse tail tip fibroblasts, human primary skin fibroblasts isolated from non-diabetic controls and HNF1A MODY patients were successfully reprogrammed using STEMCCA vectors. Multiple colonies were obtained 3 to 4 weeks after lentiviral transduction ( Figure 4A ). Since initially we encountered very low efficiency of successful expansion of reprogrammed after picking up and passaging single colonies, a different procedure was tested, where the generated colonies were detached together with nonreprogrammed fibroblasts and seeded onto gelatin-coated wells. After 0.5 h most of the fibroblasts, in contrast to reprogrammed cells, had already attached to the bottom of the well, which enabled a significant enrichment of the floating cell population with reprogrammed cells. Non-adhered cells were collected, seeded on Matrigel and further cultured. This step was helpful in successful expansion of human reprogrammed cells in our hands.
Further characterization of the obtained control and HNF1A MODY reprogrammed cells confirmed silencing of lentiviral reprogramming construct in two of four lines (Ctr Repro 2 and HNF1A MODY Repro 1, Figure 4B ). Both control and HNF1A MODY cells expressed pluripotency markers, as shown using immunofluorescence analysis of OCT3/4A, SSEA4, TRA-1-60, and TRA-1-81 ( Figure 4C,D) . Concomitantly, they formed embryoid bodies after removal of bFGF stimulation and seeding on non-adherent dishes ( Figure 5A ). When EBs were transferred to the adherent, Matrigelcoated wells, the outgrowth of differentiating cells could be detected in the following days ( Figure 5A ). These cells expressed markers characteristic for all three germ layers, confirming the broad differentiation potential of generated human reprogrammed cells ( Figure 5 A,B) . Nevertheless, despite multiple cell injections into immunocompromised mice, no teratoma generation was observed. In case of Ctr Repro 2, one of the injections resulted in development of malignant epithelial tumor ( Figure 6D .
In case of the direct approach, all specific markers were detectable in differentiating cell lines either derived from control or HNF1A MODY patients ( Figure 7A ). Similarly, in the method based on EB- mediated differentiation all markers, except FOXA2, were detectable in control and HNF1A MODY cells ( Figure 7B ). It must be stressed, however, that not all RT-PCR analyses produced the positive signals (Fig. 7C ). This might result from a low efficiency of differentiation or not optimal time-point chosen for particular cell line. Importantly, markers of pancreatic progenitor cells (HB9, PDX1, NKX2.2, and NKX6.1) were detectable in each reaction performed (Fig. 7C) . Nevertheless, in all cell lines studied the insulin was expressed at a very low level, what precluded performing reliable quantitative measurements ( Fig. 7A-C) . Accordingly, we could not reliably detect Cpeptide in media collected from differentiated cells, however we were able to measure the concentration of released glucagon (Fig. 7) . The presence of glucagon indicates that utilized protocols enabled generation of immature, polyhormonal pancreatic cells, which is a usual outcome of in vitro differentiation methods 24 .
Discussion
We report in this study the successful generation of murine iPSCs from wild type and diabetic db/db animals, as well as reprogrammed human cells from control individuals and diabetic HNF1A MODY patients. Both mouse iPSCs and human cells expressed pluripotency markers like Oct3/4A or Nanog and they were able to differentiate in To the best of our knowledge this is the first report indicating successful generation of iPSCs from Lep db/db mice which are the model of T2D. Liu et al. previously obtained and characterized iPSCs from NOD mice which are used to study pathophysiology of diabetes type 1 19 . Additionally, in another study such pluripotent cells were successfully differentiated into functional pancreatic beta-like insulin-producing cells which, upon transplantation into diabetic mice, reversed hyperglycemic phenotype of these animals 25 . Endothelial dysfunction is an important complication associated with T2D 26 . Both hyperglycemia and insulin resistance contribute to impaired physiology of endothelial cells by increasing reactive oxy- gen species, production of vasoconstrictive factors, and decreasing NO bioavailability 27 . Interestingly, many reports indicated that diabetes negatively affects a heterogeneous population of endothelial (proangiogenic) progenitor cells 28, 29 , claimed to originate from bone marrow 22 . Obesity and insulin resistance, the hallmarks of T2D, lead to elevated leptin levels which in turn can result in tissue leptin resistance and endothelial dysfunction 30 . Additionally, leptin receptor was reported to mediate the mobilization of bone marrowderived proangiogenic progenitor cells 31 . The existence of endothelial progenitors in bone marrow, specific set of markers which should be used for their characterization, and their real contribution to the process of angiogenesis is still disputable 32 , hence better models are required. Moreover, leptin whose signaling pathways exerted through ObR receptor are abrogated in db/db mice, was previously demonstrated to be a proangiogenic factor 33, 34 and regulator of vascular contractility 35, 36 . On the other hand, hyperleptinemia and tissue leptin resistance, being the hallmarks of obese diabetic patient and db/db animals, negatively affect functioning of endothelial cells and constitute important risk factors for the development of cardiovascular disease 30 . Taking this into consideration we decided to evaluate the potential of db/db iPSCs to differentiate towards endothelial cells. We demonstrated here the successful generation of CD34 1 Tie-2 1 population of progenitor-like cells of endothelial morphology, expressing active endothelial nitric oxide synthase, from both control and db/db iPSCs. Importantly, despite similar expression of endothelial markers, the proangiogenic activities of the db/db iPSC-derived cells were impaired as that of the mature endothelial cells isolated from db/db mice. This suggests that iPSC-derived endothelial-like cells may be useful in investigating the intrinsic cellular mechanisms associated with endothelial dysfunction in diabetes of different genetic background.
Since expression of CD34 is characteristic for progenitor cells 32 , the obtained population of differentiated cells could be considered as enriched in endothelial progenitor-like cells. The presence of Tie-2 protein, the receptor recognized by angiopoietin-1 (Ang1), a potent proangiogenic factor 37 , further confirms their endothelial phenotype. Interestingly, within the iPSCs colonies from which successful generation of CD34
1 Tie-2 1 populations was achieved we observed lower efficiency of differentiation in db/db cells. This might be in line with the decreased expression of heme oxygenase-1, angiotensinogen and proteoglycan-4 in db/db iPSCs. Among these factors, heme oxygenase-1 is required for proper angiogenic function of mature endothelial cells 38 and bone marrow-derived proangiogenic cells [ref. 22, reviewed in ref. 39] . The role of angiotensinogen and proteoglycan-4 in endothelial differentiation and physiology has not been extensively studied, however, they can facilitate development of hemangioblasts 20, 21 . Differentiated db/db cells exhibited impaired angiogenic potential in endothelial sprouting assay. Schiekofer et al. demonstrated that db/db mice have reduced basal capillary density and impaired ischemia-induced vascular remodeling which was associated with altered expression patterns of angiogenesis-related factors in db/db animals 40 . We also showed that proangiogenic cells derived from bone marrow of db/db mice display lower migratory capacity and reduced formation of capillaries both in 2D culture on Matrigel and in 3D culture of spheroids embedded in collagen 41 . Our present results could additionally indicate that leptin plays an important role in embryonic development of endothelial cells, although more studies are necessary to draw reliable conclusions.
In contrast to human T2D, Maturity Onset Diabetes of the Young 3 is a monogenic disease and results from the mutations in HNF-1a transcription factor. Although impaired function of only one protein is linked to the pathophysiology of HNF1A MODY, the molecular mechanisms responsible for the clinical outcome of the patients are not fully understood, mainly due to the poor accessibility of affected tissues. Generation of patient-specific iPSCs could be an important 17 . However, the authors did not perform pancreatic differentiation of those cells.
The reprogrammed cells obtained in our work expressed pluripotency markers like OCT3/4A, SSEA4, TRA-1-60 and TRA-1-81 and differentiated in vitro towards cells originating from three germ layers. However, despite positive staining for pluripotency and lineage-commitment markers, they were not able to form teratomas after subcutaneous administration into immunocompromised mice. This could indicate that the obtained cell lines represent only partially reprogrammed cells 42 . Alternatively, our method of establishing stable iPSC lines could result in heterogeneous population of partially and fully reprogrammed cells with varying proportions of both populations. In this scenario, the lack of teratoma formation could result from too low number of bona fide iPSCs among injected cells.
Our data indicate that obtained iPSCs could be successfully differentiated into cells of pancreatic lineage, expressing the insulin gene and producing glucagon. Importantly, in view of this differentiation potential, lack of teratoma formation can be considered as beneficial characteristic increasing the safety of possible future clinical utilization of such cells. Utilization of such patient-specific cells to generate cells of pancreatic lineages would provide an excellent tool to study molecular mechanisms responsible for impaired insulin production in HNF1A MODY patients and the exact role of HNF-1a in this process. The proof-of-concept of such approach was provided by Hua et al. with iPSCs derived from MODY2 patients who carry the mutations in glucokinase encoding gene 18 . Those cells could be differentiated into mature b cells with similar efficiency as control counterparts and recapitulated the clinical phenotype of the patients. This study highlights also the important issue of utilization of proper control cells which the authors generated by targeted gene modifications with zinc finger nucleases. Such approach enables the direct comparison of mutated and corrected cells with the same genetic background. In our study, the control cells were derived from nondiabetic individuals so the possibility of differences originating from different genetic background of HNF1A MODY reprogrammed cells should be taken into consideration. Nevertheless, the level of expression of insulin gene in our in vitro differentiated pancreatic lineage was too low for reliable quantitative comparisons and mechanistic study of molecular pathways. One can suppose that the final steps of differentiation within in vivo niche can be more effective 18 During the revision of this manuscript, Pagliuca et al. reported novel in vitro differentiation approach leading to generation of functional human pancreatic b cells from pluripotent stem cells 24 . Importantly, such stem-cell-derived glucose-responsive and monohormonal insulin-producing b cells demonstrated features of mature adult counterparts. This is of great importance since previous protocols, including those utilized in this study enabled predominantly to obtain immature, polyhormonal cells 24, 43 . Accordingly, our differentiation approaches led to generation of cells expressing insulin and glucagon.
In summary we report in this study the generation of mouse db/db iPSCs as well as patient-specific HNF1A MODY reprogrammed cells which could be considered as important tools for investigation of molecular mechanisms responsible for pathophysiology of different types of diabetes. Further studies should elucidate the potential of such cells in modeling clinical phenotypes observed in diabetic patients.
Methods
Mice. Lep db/db and control mice were purchased from Charles River. C57BL/6J mice (Charles River) were used to prepare mouse embryonic fibroblasts constituting a feeder layer for the growth of iPSCs. Foxn1nu immunodeficient mice utilized in teratoma formation assay were purchased from Harlan Laboratories. Mice were maintained under the specific pathogen free conditions, in individually ventilated www.nature.com/scientificreports SCIENTIFIC REPORTS | 5 : 8597 | DOI: 10.1038/srep08597cages, with full access to food and water. All procedures involving the use of animals were performed according to approved guidelines. All animal experiments were approved by the Local Ethical Committee for Animal Research at the Jagiellonian University (approval no. 51/2012, 101/2013, 208/2013).
Preparation and culture of murine fibroblasts. Somatic fibroblasts were isolated from tails of 3-4 month old Lep db/db (N 5 5) and control mice (N 5 5). Tails were excised, peeled, minced into smaller pieces and subsequently digested in collagenase II solution (1.5 mg/mL, Life Technologies) for 3 hours. Tissue fragments were centrifuged and seeded onto gelatin-coated wells of 6-well plates in DMEM (Lonza) containing 10% FBS (Lonza), penicillin (100 U/mL) and streptomycin (100 mg/mL, both from Sigma-Aldrich). The same medium was used for further culture of the cells.
Mouse embryonic fibroblasts (MEFs) were obtained from 13-15 day old C57BL/6J embryos. After isolation from the uterus, embryos were washed twice in PBS and subjected to the head and visceral tissues removal. The remaining parts were minced and digested in 0.25% trypsin/EDTA solution (1 mL per embryo, Lonza) for 2 hours. Subsequently, fresh DMEM medium containing 10% FBS, penicillin (100 U/mL) and streptomycin (100 mg/mL) was added (5 mL per embryo), obtained cells and tissue fragments were centrifuged (200 3 g, 5 minutes) and seeded onto 75 cm 2 flasks. The same type of medium was used for further culture of MEFs. For mitotical inactivation of these cells, mitomycin C (Sigma-Aldrich) was added to the culture medium at the concentration of 10 mg/mL for 3 hours. Subsequently, inactivated MEFs (iMEF) were seeded to constitute a feeder layer for growth of either mouse iPSCs (1. HNF1A gene leading to the shift in protein coding frame. 6 mm skin biopsies were transferred into PBS (Mg 21 and Ca 21 free) supplemented with penicillin (100 U/mL), streptomycin (100 mg/mL) and amphotericin B (10 mg/mL, Sigma-Aldrich). Dermis was subsequently separated from epidermis and cut into small pieces which were digested in collagenase II (2.75 mg/mL) and DNaseI (1 mg/mL, Merck) solution. Released cells and tissue fragments were then centrifuged (200 3 g, 5 minutes), suspended in fresh DMEM medium containing 10% FBS, penicillin (100 U/mL), streptomycin (100 mg/mL) and amphotericin B (10 mg/mL) and seeded on a gelatincoated wells of 6-well plate. The same medium was used for further culture of human fibroblasts.
Control, non-diabetic samples were obtained in the Clinic of Surgery, Collegium Medicum of Jagiellonian University, Krakow, from two non-diabetic patients undergoing routine surgery. For this purpose, surgical incisions were prolonged for 4-6 mm, and skin biopsies were collected. Further isolation of human fibroblasts was performed following the same procedures as MODY samples.
Production of VSV-G pseudotyped lentiviral vectors. Production of VSV-G pseudotyped lentiviral vectors was performed according to the previously described protocol 44 . Briefly, 7 3 10 6 293 T cells (kindly gifted by dr. Maciej Wiznerowicz, Greater Poland Cancer Center, Poznan, Poland) were seeded onto 10 cm dishes in the DMEM medium containing 10% FBS, penicillin (100 U/mL) and streptomycin (100 mg/mL) and subsequently subjected to the triple plasmid transfection with polyethylenimine (PEI, Polysciences Inc.) as a transfectant reagent. Reprogramming vectors were produced utilizing hSTEMCCA plasmid construct containing four transcription factors: OCT3/4A, KLF4, SOX2 and c-MYC within one expression cassette (kindly provided by dr. Gustavo Mostoslavsky, Boston University, USA 45 ) whereas in case of control vectors, FUGW plasmid, harboring GFP cDNA, was used (Addgene 14883). Additionally, psPAX2 and pMD2.G plasmids (kindly provided by dr Maciej Wiznerowicz, Greater Poland Cancer Center) served as a source of tat, rev, gag/pol and VSV-G, respectively. 48 h post-transfection, media containing vectors were collected, filtered through 0.8 mm filters (Millipore), aliquoted, and frozen at 280uC.
Reprogramming of mouse and human fibroblasts. 2.5 3 10 4 murine fibroblasts isolated from wild type as well as Lep db/db mice were seeded on wells of 24-well plate and transduced with either reprogramming (hSTEMMCA) or control, FUGW vectors, in the presence of 4 mg/mL of polybrene (Sigma-Aldrich). 24 h posttransduction media containing vector particles were replaced with fresh culture media, in which the cells were grown until full confluency. Subsequently, fibroblasts were trypsinized (0.25% trypsin/EDTA solution) and transferred to the 6-well plates covered with mitotically inactivated MEFs in the iPSCs medium consisting of DMEM supplemented with 20% FBS, penicillin (100 U/mL), streptomycin (100 mg/mL), 1% non-essential amino acids (Life Technologies), 0.1 mM 2-mercaptoethanol (Life Technologies) and 1000 U/ml leukemia inhibitory factor (LIF, Millipore). The medium has been changed daily until the colonies resembling embryonic stem cells emerged. Colonies were subsequently picked, trypsinized (0.25% trypsin/EDTA solution) and seeded on the new wells of 24-well plate coated with mitotically inactivated MEFs. Control and Lep db/db iPSCs were further expanded and characterized.
For reprogramming of human fibroblasts, 2.5 3 10 4 control and HNF1A MODY cells were seeded on gelatin-coated (Sigma-Aldrich) 24-well plates and transduced with either reprogramming (hSTEMMCA) or control, FUGW vector in the presence of 4 mg/mL of polybrene (Sigma-Aldrich). 24 h post-transduction media containing vector particles were replaced with human iPSC medium consisting of KnockOut DMEM (Life Technologies) supplemented with 20% KnockOut Serum Replacement (KSR, Life Technologies), penicillin (100 U/mL), streptomycin (100 mg/mL), 1% non-essential amino acids, 0.1 mM 2-mercaptoethanol and 10 ng/ml of human bFGF (PeproTech). On 6 th day of reprogramming the cells were reseeded on either mitotically inactivated MEF-or Matrigel-(BD Biosciences) coated 60 mm dishes. The cells were fed every other day until mature colonies resembling human embryonic stem cells emerged.
Picked colonies were mechanically dissociated and seeded onto new Matrigel-or iMEF-coated 24-well plates. For the improvement of survival the ROCK inhibitor (10 mM, Abcam) was added to the iPSC culture medium 46 . The separation of reprogrammed cells was also carried out by exploiting faster adherence of nonreprogrammed fibroblasts to gelatin-coated surface. Briefly, cell suspension, dissociated by Accutase (GE Healthcare) was placed on gelatin coated dishes for 35 minutes. Floating cells enriched in human reprogrammed cells were further cultured on Matrigel-coated dishes. This procedure was repeated 3-4 times to ensure sufficient removal of non-reprogrammed cells. Reprogrammed lines from two control individuals (named Ctr Repro 1 and 2) and two HNF1A MODY patients (named HNF1A MODY Repro 1 and 2) were subsequently expanded and characterized.
Spontaneous differentiation of mouse iPSCs and human reprogrammed cellsembryoid body formation. To verify the pluripotency of obtained mouse iPSCs and human reprogrammed cells, in a first step in vitro spontaneous differentiation was performed. Briefly, mouse iPSCs and human reprogrammed cells growing on iMEFcoated wells suspended in either mouse iPSC differentiation medium (DMEM supplemented with 20% FBS, penicillin (100 U/mL), streptomycin (100 mg/mL), 1% non-essential amino acids and 0.1 mM 2-mercaptoethanol) or human iPSC differentiation medium (KnockOut DMEM supplemented with 20% KnockOut Serum Replacement, penicillin (100 U/mL), streptomycin (100 mg/mL), 1% nonessential amino acids and 0.1 mM 2-mercaptoethanol) and seeded on non-adherent 100 mm dishes. After 5 days, mouse EBs were transferred onto gelatin-coated 48-well plates and further cultured for 12 days with daily medium change. Similarly, human EBs were transferred after 5-8 days on Matrigel-coated dishes and cultured for 5-9 days. Both mouse and human differentiated cells were subsequently immunofluorescently analyzed for expression of markers characteristic for cells originating from endo-, ecto-and mesoderm.
Teratoma formation assay. Mouse iPSCs were trypsinized and reseeded on gelatincoated wells for 1 h to deplete the population of iMEFs. Floating cells were collected, centrifuged and resuspended in DMEM supplemented with 10% FBS, penicillin (100 U/mL), and streptomycin (100 mg/mL). 1.5 3 10 6 cells were injected subcutaneously into dorsal flank of immunocompromised Fox1nu mice. After approximately 8 weeks tumors were excised, embedded in paraffin and subjected to histological analysis with hematoxilin and eosin staining.
Human reprogrammed cells were detached with Accutase, centrifuged and resuspended in human iPSCs differentiation medium. 1-2 3 10 6 cells were injected subcutaneously into dorsal flank of immunocompromised Fox1nu mice. After approximately 8 weeks the sole resulting tumor were excised, embedded in paraffin and subjected to histological analysis with hematoxilin and eosin staining.
Differentiation of mouse iPSCs into endothelial cells. Mouse iPSCs were trypsinized and reseeded on gelatin-coated wells for 1 h to deplete the population of iMEFs. Floating cells were collected, centrifuged, resuspended in a-MEM (Lonza) supplemented with 10% FBS, penicillin (100 U/mL), streptomycin (100 mg/mL), 1% non-essential amino acids and 0.1 mM 2-mercaptoethanol (EDM, endothelial differentiation medium), and subsequently seeded on 12-well plates coated with collagen IV (Sigma-Aldrich; 5 mg/cm 2 , diluted in 50 mM hydrochloric acid). Cells were cultured for 4 days and then transferred to 12-well plates coated with fibronectin (Sigma-Aldrich; 20 mg/mL, 15-30 minutes at 37uC) in EDM medium supplemented with 50 ng/mL VEGF (Sigma-Aldrich). Further passaging was performed whenever cells reached around 90% confluency. After approximately 30-60 days, when majority of cells acquired endothelial-like phenotype (CD34 1 Tie-2 133 ), the medium was changed to EGM-2MV (Lonza) and the cells were further cultured for the immunophenotyping and functional assays. Differentiated cells could be kept in culture for at least 130 days without changes in the morphology, phenotype or growth capacity. days in culture. The resulting spheres were embedded in collagen I and the sprouting was assessed after 24 h.
Flow cytometry. In order to immunophenotype the cells during endothelial differentiation, they were detached with Accutase (Cytogen), washed with PBS and resuspended in PBS with 2% FBS. Subsequently, the cells were incubated with FcR blocking reagent (Miltenyi Biotech) for 10 minutes at 4uC followed by addition of specific antibodies conjugated with fluorochromes: CD34-FITC (BD Biosciences) and Tie-2-APC (Biolegend). After 30 minutes of incubation at 4uC the cells were washed with PBS, resuspended in PBS supplemented with 2% FBS and acquired on LSRII flow cytometer (BD Biosciences). Appropriate single stained samples were used for compensation of different fluorochromes. Results were analyzed by Diva software (BD Biosciences).
Endothelial sprouting assay. To form endothelial spheres, differentiating iPSCs at day 120 of culture were detached with Accutase and transferred to 10 mL of medium containing methyl cellulose [composed of 10 mL of methyl cellulose (Sigma-Aldrich; 100%) and 40 mL of EGM-2MV medium] to obtain concentration of 7500 cells/mL. Subsequently, 750 cells/well were seeded on U-shaped 96-well plate in 100 ml of medium. The plate was incubated at 37uC and the formation of spheres was assessed after 1-3 days. After the spheres were formed they were embedded in collagen type I (BD Biosciences) for evaluation of sprouting capability. Briefly, the spheres were centrifuged (45 3 g, 3 minutes, room temperature) and resuspended in 500 mL of methyl cellulose supplemented with 30% FBS. Subsequently, 500 mL of HBSS containing phenol red (Sigma-Aldrich) were mixed with 4 mL of 100% collagen I solution followed with its neutralization with sterile 200 mM NaOH. 500 mL of collagen solution was mixed with 500 mL of sphere suspension and immediately poured on 24-well plate. After 15 minutes of incubation at 37uC, the wells were covered with 200 mL of EGM-2MV medium. The sprouting was assessed after 24 h and 48 h using an inverted microscope.
Nitric oxide production. The production of NO was measured in the culture medium of differentiated cells at day 130 of culture, using gas-phase chemiluminescence reaction. Nitrite, the major oxidation product of NO in the absence of oxyhemoglobin or superoxide anion, is formed when NO reacts with dissolved oxygen. Therefore the nitrite formed in the medium was reduced in a solution of acetic acid in the presence of iodide 47 and the measurement was performed with 280i Nitric Oxide Analyzer (NOA TM , Sievers) equipped with high sensitivity detector for NO.
Pancreatic differentiation -direct method. The direct differentiation approach follows a modified protocol by Maehr et al. 48 . Accordingly, human reprogrammed cells (Ctr Repro 1 and 2 as well as HNF1A MODY Repro 1 and 2) were seeded onto Matrigel coated 12-well plates. The cells were cultured in human iPSCs medium until 80% confluency was observed followed by the first change to differentiation medium. During the four differentiation stages the differentiation medium was replaced six times: at day 1 st it composed of Advanced RPMI (Life Technologies) supplemented with Wnt3a (25 ng/mL, Sigma-Aldrich), Activin A (100 ng/mL, PeproTech), 1% Glutamax (Life Technologies), penicillin (100 U/mL) and streptomycin (100 mg/ mL); on day 3 rd it composed of Advanced RPMI supplemented with 0.2% FBS, Activin A (100 ng/mL), 1% Glutamax, penicillin (100 U/mL) and streptomycin (100 mg/ mL); on day 5 th it composed of Advanced RPMI supplemented with 2% FBS, FGF10 (50 ng/mL, PeproTech), 25 mM KAAD-Cyclopamine (Sigma-Aldrich), 1% Glutamax, penicillin (100 U/mL) and streptomycin (100 mg/mL), on day 9 th it composed of DMEM supplemented with FGF10 (50 ng/mL), 25 mM KAADCyclopamine, 2 mM retinoic acid (Sigma-Aldrich), B27 supplement (1x, Life Technologies), 1% Glutamax, penicillin (100 U/mL) and streptomycin (100 mg/mL); on day 13 th it composed of DMEM supplemented with FGF10 (50 ng/mL), 300 nM Indolactam V (Sigma-Aldrich), B27 supplement (1x, Life Technologies), 1% Glutamax, penicillin (100 U/mL) and streptomycin (100 mg/mL); and on day 19 th it composed of DMEM supplemented with 10 mM DAPT (Sigma-Aldrich), B27 supplement (1x), 1% Glutamax, penicillin (100 U/mL) and streptomycin (100 mg/ mL). With every step the morphological changes were documented and RNA was isolated.
Pancreatic differentiation -embryoid body-based method. The differentiation approach based on a prior EBs formation was performed according to the modified protocol described in Schroeder et al.
49
. Ctr Repro 2 and HNF1A MODY Repro 1 were used in this experiment. EBs were formed as described for spontaneous www.nature.com/scientificreports differentiation of human reprogrammed cells and cultured in non-adherent conditions for 5 days. Subsequently they were seeded onto Matrigel-coated dishes (60 mm) for further 9 days in the same medium during which spontaneous differentiation occurred. On day 14 th the cells were washed 2 times with PBS, trypsinized and removed from the dish surface with a cell scraper. Collected cells were suspended in differentiation medium composed of DMEM/F12 (Lonza) supplemented with 10% FBS, 100 mM putrescine (Sigma-Aldrich), 20 nM progesterone (Sigma-Aldrich), laminin (1 mg/mL, Sigma-Aldrich), insulin (25 mg/ mL, Sigma-Aldrich), 30 nM sodium selenite (Sigma-Aldrich), transferrin (50 mg/mL, Sigma-Aldrich), B27 supplement (1x), penicillin (100 U/mL) and streptomycin (100 mg/mL) and seeded onto collagen I coated dishes (1:70 in 0.2 N acetic acid). Differentiation medium was changed every other day and RNA isolation was performed on day 19, 24 and 30.
Differentiation of Panc-1 pancreatic cancer cell line. Panc-1 cells (ATCC, CRL-1469) were cultured in DMEM medium containing 10% FBS, penicillin (100 U/mL) and streptomycin (100 mg/mL) and differentiated toward insulin-and glucagonexpressing cells according to Suzuki J et al. protocol 50 . Briefly, 1 3 10 6 cells cultured on 6-well plate were washed with PBS and treated for 30 s with 0.05% trypsin/EDTA solution at room temperature. Trypsin was removed, cells were washed three times with PBS and subsequently cultured for 6 days in DMEM/F12 medium containing 17.5 mM glucose and 1% BSA. Media were collected and subjected to enzyme immunoassay (EIA) for measurement of glucagon concentration.
Enzyme immunoassay (EIA). EIA assay (Sigma-Aldrich) for measurement of glucagon concentration was performed according to manufacturer's protocol. Media collected from differentiated Panc-1 cells and from the last day of differentiation of control and HNF1A MODY reprogrammed cells via direct and EB-mediated protocols were used.
Isolation of RNA, RT-PCR and real-time qPCR. Total cellular RNA was isolated utilizing the phenol/chloroform extraction. To ensure complete removal of genomic DNA contamination samples were treated with DNase I (Life Technologies). Reverse transcription was performed with M-MuLV Reverse Transcriptase (Thermo Scientific) and oligo(dT) primers (Promega). PCR reaction was performed using Taq polymerase (Promega) under following conditions: 95uC for 5 minutes, 40 cycles of 95uC for 30 seconds, annealing temperature for 60 seconds and 72uC for 45 seconds, with final elongation at 72uC for 5 minutes. The PCR products electrophoresis was performed in 2% agarose gel. Quantitative real-time PCR with melt curve analysis of amplified products was performed with StepOne Plus cycler (Applied Biosystems) and SYBRH Green JumpStart TM Taq ReadyMix TM (Sigma-Aldrich). In murine iPSCs the expression of Oct3/4A, Nanog, Sox2, Hmox1, Prg4 and Agt was determined by quantitative RT-PCR, while in human reprogrammed cells OCT3/4A and markers of pancreatic differentiation were checked 48 . The applied PCR program for detection of pancreatic differentiation markers followed the same setting as for OCT3/4A except for the annealing temperature which was reduced to 54uC and additionally, 6 mL (instead of 2 mL) of cDNA samples were used. After first examinations the markers with low gene expression, i.e. SOX17 and INS were also amplified by PCR using a highly sensitive DNA polymerase (Q5HHigh-Fidelity DNA Polymerase [2000 U/mL], New England Biolabs). In case of direct differentiation RT-PCR was performed for cells from each patients and in case of embryoid bodiesmediated differentiation RT-PCR was performed in duplicates. Additionally, silencing of the hSTEMCCA vector was tested by amplification of sequence specific for transgene cassette with primers designed to recognize c-MYC (forward primer) and WPRE (reverse primer) part of the vector construct within the cellular transcripts 51 . EF2 was used as the housekeeping gene. The sequences of primers used in the study are provided in Table 1 . Subsequently, cells were washed 5 times with PBS and incubated with secondary antibodies (AlexaFluor, Life Technologies) for 1 h in room temperature. This was followed by incubation with 1 mg/mL of Hoechst 33342 in PBS for 10 minutes in room temperature and 4 washing steps with PBS. Cells were eventually visualized under fluorescent microscope (Nikon Eclipse TS100). Additionally, mouse iPSCs were stained with CDy1 (kindly provided by dr Young-Tae Chang, Department of Chemistry, National University of Singapore), a fluorescent dye which selectively marks mouse and human pluripotent stem cells 52 . For this purpose, iPSCs were incubated with 0.1 mg/mL of CDy1 diluted in iPSCs culture medium for 1 h at 37uC. Cells were than washed with PBS and further cultured for 2 h in fresh medium. Colonies were visualized under fluorescent microscope.
Statistical analysis. Data are presented as mean 1 SEM. Unpaired two-tailed t-test or exact Fisher test were used to analyze statistical significance. Results were considered as significant at p , 0.05.
